Media stories about MedEquities Realty Trust (NYSE:MRT) have trended positive on Saturday, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. MedEquities Realty Trust earned a coverage optimism score of 0.31 on Accern’s scale. Accern also gave media headlines about the financial services provider an impact score of 45.7187090354062 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

MedEquities Realty Trust stock opened at $10.13 on Friday. The firm has a market cap of $319.82, a price-to-earnings ratio of 8.89 and a beta of -0.21. MedEquities Realty Trust has a twelve month low of $9.67 and a twelve month high of $13.06.

MedEquities Realty Trust (NYSE:MRT) last posted its earnings results on Wednesday, February 21st. The financial services provider reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.13). The company had revenue of $16.23 million for the quarter, compared to analysts’ expectations of $16.31 million. MedEquities Realty Trust had a return on equity of 5.99% and a net margin of 34.96%. The firm’s quarterly revenue was up 13.8% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.06) EPS. equities analysts forecast that MedEquities Realty Trust will post 1.21 EPS for the current year.

A number of brokerages recently issued reports on MRT. KeyCorp lowered their price target on MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Monday, April 16th. Cantor Fitzgerald reiterated a “buy” rating and issued a $14.00 price target on shares of MedEquities Realty Trust in a report on Wednesday, February 21st. ValuEngine lowered MedEquities Realty Trust from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. B. Riley set a $13.00 price target on MedEquities Realty Trust and gave the company a “buy” rating in a report on Thursday, February 22nd. Finally, Citigroup lowered their price target on MedEquities Realty Trust from $12.00 to $10.00 and set a “neutral” rating for the company in a report on Thursday, March 1st. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. MedEquities Realty Trust presently has an average rating of “Hold” and a consensus target price of $12.33.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with's FREE daily email newsletter.